These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4508248)

  • 1. Hypergastrinaemia due to an excluded gastric antrum: a proposed method for differentiation from the Zollinger ellison syndrome.
    Korman MG; Scott DF; Hansky J; Wilson H
    Aust N Z J Med; 1972 Aug; 2(3):266-71. PubMed ID: 4508248
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastric acid secretion and diagnosis of Zollinger-Ellison syndrome.
    Lewin MR; Stagg BH; Clark CG
    Br Med J; 1973 Apr; 2(5859):139-41. PubMed ID: 4699593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum gastrin levels in the differential diagnosis of recurrent peptic ulceration due to retained gastric antrum.
    Webster MW; Barnes EL; Stremple JF
    Am J Surg; 1978 Feb; 135(2):248-52. PubMed ID: 626303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Radioisotope scan--a possible aid in differentiating retained gastric antrum from Zollinger-Ellison syndrome in patients with recurrent peptic ulcer.
    Chaudhuri TK; Shirazi SS; Condon RE
    Gastroenterology; 1973 Oct; 65(4):697-8. PubMed ID: 4583568
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous transhepatic venous sampling of gastrin: value in sporadic and familial islet-cell tumors and G-cell hyperfunction.
    Glowniak JV; Shapiro B; Vinik AI; Glaser B; Thompson NW; Cho KJ
    N Engl J Med; 1982 Jul; 307(5):293-7. PubMed ID: 7088088
    [No Abstract]   [Full Text] [Related]  

  • 6. Retained gastric antrum syndrome: a forgotten, treatable cause of refractory peptic ulcer disease.
    Gibril F; Lindeman RJ; Abou-Saif A; Shojamanesh H; Roy PK; Peghini PL; Reynolds JC; Lubensky IA; Jensen RT
    Dig Dis Sci; 2001 Mar; 46(3):610-7. PubMed ID: 11318541
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic value of secretin provocation test.
    Ishimori A; Tsuda K; Yamagata S; Miura Y; Kawamura T
    Tohoku J Exp Med; 1975 Jun; 116(2):173-7. PubMed ID: 1154384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum gastrin and acid secretory levels in patients with the Zollinger-Ellison syndrome.
    Sanchez RE; Passaro E
    Surg Forum; 1969; 20():314-5. PubMed ID: 5383069
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis of the Zollinger-Ellison syndrome].
    Fisher AA
    Klin Med (Mosk); 1980 Dec; 58(12):11-7. PubMed ID: 7009977
    [No Abstract]   [Full Text] [Related]  

  • 10. The radioimmunoassay of gastrin. Clinical considerations.
    McGuigan JE
    JAMA; 1976 Jan; 235(4):405-6. PubMed ID: 946085
    [No Abstract]   [Full Text] [Related]  

  • 11. Secretin and the Zollinger--Ellison syndrome: reliability of secretin tests and pathogenetic role of secretin.
    Stage JG; Stadil F; Rehfeld JF; Fahrenkrug J; Muckadell OB
    Scand J Gastroenterol; 1978; 13(4):501-11. PubMed ID: 675163
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current diagnosis and surgical treatment when the gastric antrum is retained after Billroth II-operations].
    Wedell J; Peters H; Fritsch WP; Hausamen TU
    Chirurg; 1974 Jun; 45(6):257-61. PubMed ID: 4409097
    [No Abstract]   [Full Text] [Related]  

  • 13. Extragastric gastrinoma or G-cell hyperplasia of the antrum? The preoperative diagnosis in a case of hypergastrinaemia.
    Gray GR; Gillespie G; Gordon I
    Br J Surg; 1976 Aug; 63(8):596-8. PubMed ID: 953461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts on physiological control of gastric acid secretion. Clinical applications.
    Ivey KJ
    Am J Med; 1975 Mar; 58(3):389-97. PubMed ID: 234680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zollinger-Ellison syndrome].
    Feurle G; Ketterer H; Creutzfeldt W
    Med Klin; 1972 Jan; 67(2):37-40. PubMed ID: 4551075
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antral G cell hyperplasia in the genesis of peptic ulcer].
    De Graef J; Keuppens F; Willems G; Woussen-Colle MC
    Gastroenterol Clin Biol; 1979 Jan; 3(1):3-6. PubMed ID: 437397
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in diagnosis of gastric function: gastric secretory analysis, intragastric titration, endocrine provocation tests (author's transl)].
    Becker HD
    Z Gastroenterol; 1978 Mar; 16(3):118-25. PubMed ID: 636505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of glucagon provocation test in the diagnosis of hypergastrinemia.
    Nakanome C; Ishimori A; Goto Y; Yamazaki T; Kameyama J; Sasaki I; Inui M; Furukawa Y; Komatsu K
    Gastroenterol Jpn; 1981; 16(3):213-22. PubMed ID: 6114893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bioassay in the diagnosis of ulcerogenic tumors.
    Wilson SD; Mathison JA; Schulte WJ; Ellison EH
    Arch Surg; 1968 Sep; 97(3):437-43. PubMed ID: 5675956
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormones and peptic ulcer.
    Brooks FP
    Am J Gastroenterol; 1973 Sep; 60(3):250-4. PubMed ID: 4745167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.